NanoKnife treatment for advanced pancreatic cancer
Part of Cancer, Digestive system clinical trials.
This trial studies a procedure called NanoKnife IRE for pancreatic cancer that cannot be removed surgically after standard chemotherapy or radiation. It uses electric pulses to destroy tumor cells and may be an option for patients who have completed other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your pancreatic cancer is locally advanced and cannot be surgically removed
- You have completed standard chemotherapy and/or radiation at least 5 weeks before treatment
- Your blood clotting test (INR) is less than 1.5
- You are willing to follow the study plan and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how safe CyberKnife is when used to treat some borderline resectable or locally advanced pancreatic cancers after chemotherapy. It may help patients by targeting the tumor with precise radiation, while researchers closely watch for side effects.
This trial tests a tiny implantable device that measures how different chemotherapy drugs work on your tumor during surgery. The goal is to find the most effective treatment for your specific cancer.
This trial tests a new drug called mitazalimab injected directly into the tumor, combined with a special electrical procedure that kills cancer cells. It is for people whose pancreatic cancer has not spread but cannot be removed by surgery.
This study looks at how well combining standard chemo with a targeted local treatment works for people with locally advanced pancreatic cancer. It may help control the cancer in the area of origin and improve outcomes compared with chemo alone.
This trial tests a treatment that uses tiny electric pulses to destroy liver tumors (NanoKnife) combined with immunotherapy to boost your immune system against cancer. It's for people with colorectal cancer that has spread to the liver and hasn't responded enough to chemotherapy.
This trial tests a new treatment that uses ultrasound to help chemotherapy reach liver tumors in people with advanced pancreatic cancer. It may help shrink tumors and improve how well the chemotherapy works.
Hear when a new Pancreatic Cancer Non-resectable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.